scholarly article | Q13442814 |
editorial | Q871232 |
P6179 | Dimensions Publication ID | 1032013510 |
P356 | DOI | 10.1186/1741-7015-11-183 |
P932 | PMC publication ID | 3826871 |
P698 | PubMed publication ID | 23945332 |
P5875 | ResearchGate publication ID | 255954826 |
P2093 | author name string | Jun-Ichi Kira | |
P2860 | cites work | Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial | Q34941384 |
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial | Q35065987 | ||
Global epidemiology of HTLV-I infection and associated diseases | Q36254899 | ||
Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy | Q36981737 | ||
Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study | Q39138593 | ||
Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs | Q39149901 | ||
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis | Q39291807 | ||
Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. | Q39305599 | ||
Safety of long-term treatment of HAM/TSP patients with valproic acid | Q39321719 | ||
Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system | Q39541717 | ||
Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study | Q39611506 | ||
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells | Q42071070 | ||
Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy | Q45087228 | ||
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. | Q55239353 | ||
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. | Q55242452 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin B | Q183206 |
thiamine(1+) ion | Q83187 | ||
paraparesis | Q3363589 | ||
Human T-lymphotropic virus 1 | Q1280388 | ||
spastic paraparesis | Q55083510 | ||
P304 | page(s) | 183 | |
P577 | publication date | 2013-08-15 | |
P1433 | published in | BMC Medicine | Q4835947 |
P1476 | title | Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) | |
P478 | volume | 11 |
Q38972538 | Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon |
Q36157642 | Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tr |
Q38878420 | Update on Neurological Manifestations of HTLV-1 Infection |
Search more.